TrialCancer chemotherapy and pharmacology2019

Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia.

Ken Ogasawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.